H.R. 5526House118th Congress (2023-2025)Passed House

Seniors’ Access to Critical Medications Act of 2024

Introduced September 18, 2023

AI-Generated Summary

Updated January 20, 2026 at 11:29 AM UTC

The Seniors’ Access to Critical Medications Act of 2024 updates Medicare rules to make it easier for seniors to get important outpatient drugs and to cover the equipment needed for home infusion therapy. It clarifies when doctors can provide covered Part D drugs without violating the self‑referral ban, adds Medicare coverage for external infusion pumps and certain home infusion drugs, and provides additional funding for the Medicare Improvement Fund.

Key Provisions

  • Clarifies the in‑office ancillary services exception for covered Part D drugs from 2025‑2029, requiring a face‑to‑face visit, a prior paid service, and an ongoing relationship with the prescriber.
  • Requires the HHS Secretary to report to Congress within three years on how many individuals benefited, cost changes, drug types, and price impacts from the new exception.
  • Expands Medicare coverage to external infusion pumps and associated home infusion drugs that must be administered or supervised by a health‑care professional, used at least 12 times a year, and meet specific safety criteria, effective one year after enactment.
  • Increases the Medicare Improvement Fund by $114 million.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

17 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Finance.

September 24, 2024

View full timeline
HouseIntro Referral

Introduced in House

September 18, 2023

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

September 18, 2023

HouseCommittee

Referred to the Subcommittee on Health.

September 22, 2023

HouseCommittee

Subcommittee Consideration and Mark-up Session Held

March 12, 2024

HouseCommittee

Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 19 - 6.

March 12, 2024

HouseCommittee

Committee Consideration and Mark-up Session Held

June 12, 2024

HouseCommittee

Ordered to be Reported (Amended) by the Yeas and Nays: 41 - 0.

June 12, 2024

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-691, Part I.

September 19, 2024

HouseCommittee

Committee on Ways and Means discharged.

September 19, 2024

HouseCalendars

Placed on the Union Calendar, Calendar No. 585.

September 19, 2024

HouseFloor

Mr. Bucshon moved to suspend the rules and pass the bill, as amended.

September 23, 2024 • 3:58 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5587-5588)

September 23, 2024 • 3:58 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 5526.

September 23, 2024 • 3:58 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)

September 23, 2024 • 4:06 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5587)

September 23, 2024 • 4:06 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

September 23, 2024 • 4:06 PM

HouseFloor

The title of the measure was amended. Agreed to without objection.

September 23, 2024 • 4:06 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Finance.

September 24, 2024

Floor Debate

3 members

What members said about H.R. 5526 on the floor

2 Republicans1 Democrat
Diana Harshbarger
Rep. Diana HarshbargerR-TN-1 · Sep 23, 2024

Mr. Speaker, I rise today in strong support of H.R. 5526, the Seniors' Access to Critical Medications Act. I thank my co-lead, Democrat Representative Wasserman Schultz, and House Energy and Commerce…

Larry Bucshon
Rep. Larry BucshonR-IN-8 · Sep 23, 2024

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5526) to amend title XVIII of the Social Security Act to clarify the application of the in-office ancillary services exception to the…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Sep 23, 2024

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in support of H.R. 5526, the Seniors' Access to Critical Medications Act. This bill amends the Physician…

Bill Text

4 versions available

Reading Mode
Latest
Referred in SenateIssued September 24, 2024

IIB

118th CONGRESS

2d Session

H. R. 5526

IN THE SENATE OF THE UNITED STATES

September 24, 2024

Received; read twice and referred to the Committee on Finance

AN ACT

To amend title XVIII of the Social Security Act to clarify the application of the in-office ancillary services exception to the physician self-referral prohibition for covered outpatient drugs furnished under the Medicare program, and to provide coverage of external infusion pumps and non-self-administrable home infusion drugs under such program.


1.

Short title

This Act may be cited as the Seniors’ Access to Critical Medications Act of 2024.

2.

Clarifying the application of the in-office ancillary services exception to the physician self-referral prohibition for covered outpatient drugs furnished under the Medicare program

(a)

In general

Section 1877(b)(2) of the Social Security Act (42 U.S.C. 1395nn(b)(2)) is amended by adding at the end the following new sentence: With respect to services described in subsection (h)(6)(J) consisting of covered part D drugs (as defined in section 1860D–2(e)) furnished to an individual during the period beginning on January 1, 2025, and ending on December 31, 2029, such drugs shall be treated as having been furnished in accordance with subparagraph (A)(ii) if such drugs are picked up in a building described in subclause (I) or (II) of such subparagraph by such individual, or a family member or caregiver on behalf of such individual, or delivered to such individual by a mail, delivery, or courier service, but only if, during the 1-year period ending on the date such drugs were so furnished, such individual had a face-to-face encounter with the prescriber of such drugs (not including any such encounter conducted via telehealth), and only if such prescriber (or another physician or practitioner (as described in section 1842(b)(18)(C)) in the same practice as such prescriber (as determined by tax identification number)) furnished to such individual, during such 1-year period, another item or service for which payment was made under this title, and only if such individual has an ongoing relationship with such prescriber..

(b)

Report

Not later than 3 years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report that contains—

(1)

the number of individuals who were furnished drugs in a manner that would constitute a violation of section 1877 of the Social Security Act (42 U.S.C. 1395nn) but for the amendment made by subsection (a);

(2)

an analysis of the change in expenditures under title XVIII of such Act (42 U.S.C. 1395 et seq.) attributable to such amendment;

(3)

a description of which drugs were furnished in a manner described in paragraph (1); and

(4)

such amendment’s impact on prices for such drugs.

3.

Medicare coverage of external infusion pumps and non-self-administrable home infusion drugs

Section 1861(n) of the Social Security Act (42 U.S.C. 1395x(n)) is amended by adding at the end the following new sentence:

Beginning with the first calendar quarter beginning on or after the date that is one year after the date of the enactment of the Seniors’ Access to Critical Medications Act of 2024, an external infusion pump and associated home infusion drug (as defined in subsection (iii)(3)(C)) or other associated supplies that do not meet the appropriate for use in the home requirement applied to the definition of durable medical equipment under section 414.202 of title 42, Code of Federal Regulations (or any successor to such regulation) shall be treated as meeting such requirement if each of the following criteria is satisfied:

(1)

The prescribing information approved by the Food and Drug Administration for the home infusion drug associated with the pump instructs that the drug should be administered by or under the supervision of a health care professional.

(2)

A qualified home infusion therapy supplier (as defined in subsection (iii)(3)(D)) administers or supervises the administration of the drug or biological in a safe and effective manner in the patient’s home (as defined in subsection (iii)(3)(B)).

(3)

The prescribing information described in paragraph (1) instructs that the drug should be infused at least 12 times per year—

(A)

intravenously or subcutaneously; or

(B)

at infusion rates that the Secretary determines would require the use of an external infusion pump.

.

4.

Medicare Improvement Fund

Section 1898(b)(1) of the Social Security Act (42 U.S.C. 1395iii(b)(1)) is amended by striking $0 and inserting $114,000,000.

Passed the House of Representatives September 23, 2024.

Kevin F. McCumber,

Clerk.